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effects is by reducing platelat aggregation and rnicroembolization downstream during 
mechanical reperfusion and thereby preserving the microcirculation. 
Methods: Forty-seven patients with STEMI underwent primary angioplasty and/or stent- 
ing of native coronary arteries. Saphenous venous graft lesions and patients with end- 
stage renal disease were excluded. Twenty-seven (57.5%) patients received standard 
bolus and infusion of abciximab. Angiograms were evaluated by two blinded independent 
reviewers for Myocardial Blush Grade immediately after coronary intervention as follows: 
0, no blush; 1, minimal blush; 2, moderate blush; and 3, normal blush. All patients had 
Thrombolysis In Myocardial Infarction (TIMI) 3 grade flow at the end of the procedure. 
Results: in the abciximab group, 20/27 (74%) patients had MBG of 2-3, compared to 9/20 
(45%) in the non-abciximab group (p<0.05). In diabetics, 5/10 (60%) in the abciximab 
group had a normal blush compared to 0/5 (0%) in the non-abciximab group (p<0.05). 
Conclusion: Abciximab significantly improved myocardial microcirculation, assessed by 
MBG, after primary coronary intervention for acute ST elevation myocardial infarction. 
This effect seemed particularly prominent in the diabetic subgroup. 
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University Hospital RWTH, Aachen, Germany. 
BACKROUND: Angiographic myocardial blush grade (MBG) and corrected TIMI frame 
count (CTFC) have been suggested for evaluation of myocardial reperfusion and predic- 
tion of patient outcome after PTCA for acute myocardial infarction (AMI). The compara- 
tive prognostic value of both parameters for patient outcome is not established. 
METHODS: To evaluate the prognostic value of MBG (0/1: no or minimal blush, 2: mod- 
erate blush, and 3 normal blush) and CTFC (number of cine frames required for dye to 
reach standardized istal landmarks) all 240 patients (82% male, 63±11 years) which 
underwent PTCA for AMI on a native coronary artery at this institution between 1/96 and 
10/99 were included in this study. MBG and CTFC were determined on the final anglo- 
gram after PTCA. Patients were followed up a mean of 3±1 years after AMI to determine 
the occurrence of death. RESULTS: 59 patient died during follow-up. Patients who died 
during follow-up had a significantly lower MBG and a higher CTFC (slower flow) immedi- 
ately after PTCA. MBG (OR=0.48 per 1 grade rise; 95%C1:0.32 - 0.70, p<0.001) and 
CTFC (OR= 1.02 per 1 frame rise; 95% CI: 1.00 - 1.03, p=O.040) were both univariate 
predictors of death. In a multivariate analysis only MBG proved to be a predictor of death 
(OR=0.49; 95% CI= 0.32-0.76, p<0.001). CONCLUSION: Impaired myocardial pedusion 
as determined by a low MBG and slow flow in the infarct related artery evaluated by 
CTFC are both predictors of death during follow-up after PTCA for AMI. However, MBG 
is the stronger predictor of death. 
Parameter Dead Alive p value 
MBG 1.22±1.08 1.90±1.00 <0.001 
CTFC 41.9¢32.5 33.5±24.2 0.036 
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ratory quantitative analysis was performed for seven coronary arterial zones in patients 
having primary coronary intervention for AMI. Three infarct related arterial zones (IRA) 
and four non-infarct related zones were compared at baseline, following balloon angio- 
plasty, stenting and intracoronary nitroprusside (50-100ugm) respectively. Flow was 
determined using corrected TIMI frame counts (CTFC) for each zone following each 
intervention. Results: Average (mean+S.D.) CTFC is listed in the table. Conclusion: 
Microvascular dysfunction contributes to slow flow in the NIRA among patients with AMI. 
Concordant changes in IRA and NIRA flow and normalization ofNIRA flow in response to 
the direct vasodilator nitroprusside suggests an endothelium-independent mechanism 
and a relationship with the microvasculature of the IRA zone. This finding implies that 
improvement of flow to the infarct zone and/or vasodilator therapy may have a role in 
enhancin~ lobal myocardial blood flow in the setting of AMI. 
IRA NIRA 
Baseline 44.3+7.0 
Post PTCA 21.0+2.0 40.4+~2.9 
Post Stent 27.3+1.5 47.7+-24.9 
Nitroprusside 18.3+_5.9 27.3+_5.1 
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Brain natriuretic peptide (BNP) has been found to be elevated in acute myocardial 
ischemia, but its effect in such event is unknown. To determine whether BNP provides 
any benefit in acute ischernia, we studied 12 dogs at baseline, and total coronary artery 
ligation(OCC). Myocardial blood flow (MBF) was assessed by microsphere. Myocardial 
blood velocity (~) and volume (A) were assessed by power pulse inversion contrast 
echo.Results: BNP enhanced MBF of both risk area, especially in subendocardium 
(from 0.13 to 0,3 ml/gm/min, p<.001, figure), and non-occluded regions (from 0.75 to 
1.85 ml/gm/min, p<.001. Conclusion: BNP globally enhances perfusion both in normal 
coronary artery and in acute ischemia by recruiting collateral microcirculation. BNP has a 
great potential for acute myocardial ischemia treatment. 
A MBF 
(ml/gm/nin) 
Baseline-PreBNP 3.55±1.07 3.33+0.75 1.14_-+0.27 
Baseline-BNP 5.84+1.77** 6,35+_1.39** 3.66±1.26** 
OCC-Pre-BNP 1.17_+0.62 1.0±0.42 0.13+0.1 
OCC-BNP 1.41~0.61" 1.63+0.62" 0.26t"0.19" 
*=p<.01**=p<.001 comparing Pre-BNP versus BNP 
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Background: Previous studies have suggested that shear stress induced by intra-aortic 
balloon pumping(tABP) might result in the enhancement of NO bioactivity and increase 
blood mixing and provide favorable washing of the chamber walls.The purpose of this 
study was to assess whether IABP exerts beneficial effect on microvascular function and 
functional and clinical outcomes in patients with acute myocardial infarction(AMI). 
Methods: We randomly divided 61 patients with a first anterior AMI into two groups 
,IABP(n=30) and control groups(n=31).All patients received successful coronary angio- 
plasty within 12h the symptom onset and underwent intravenous myocardial contrast 
echocardiography(MCE).ln the IABP group, IABP therapy was performed before primary 
angioplasty and maintained 24 to 48 hours. 
Results: The improvement in regional eft ventricular function ,wall motion score and 
regional wall motion was significantly better in the IABP group than in the control 
group.Intractable congestive heart failure ,malignant ventricular arrhythmia nd pericar- 
dia1 effusion were more frequently found in the control group than in the IABP group(34% 
vs 13%,21% vs 6%,39% vs 8%,p<0.05,respectively).The frequency of sizable MCE no 
reflow phenomenon was significantly lower in the IABP group than in the control 
group(14% vs 35%,p<0.05). 
Conclusion: IABP in conjunction with coronary angioplasty isassociated with better func- 
tional and clinical outcomes compared to aogioplasty alone in patients with an anterior 
AMI. MCE findings imply that an improvement in microvascular function with IABP may 
be attributable to this better outcome. 
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Background: In the setting of acute myocardial infarction (AMI), angiographic velocity 
measurements indicate inappropriate slow flow in non-infarct related arteries (NIRA). 
The mechanism of this finding is unknown. We tested the hypothesis that microvascular 
dysfunction of the NIRA is at least in pad responsible. Methods: Angiographic ore labo- 
OCC OCC with BNP 
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Background: Patients with acute myocardial infarction may benefit from the addition of 
glycoprotein lib/Ilia inhibitors to fibrinolytic or mechanical reperfusion strategies. We 
aimed to compare 2 repedusion strategies, stenting and fibrinolysis, both combined with 
abciximab, in terms of myocardial salvage and clinical outcome. 
Methods: We enrolled 162 patients with acute myocardial infarction within 12 hours from 
onset of symptoms, assigning 81 patients to stenting plus abciximab and 81 patients to 
alteplase plus abciximab. The primary endpoint was the salvage index defined as the 
ratio between the degree of myocardial salvage and initial peffusion defect measured by 
technetium 99m sestamibi scintigraphy. Additional endpoint was the comparison of the 
incidence of major adverse clinical events between the 2 treatments at 6 and 12 months 
from randomization. 
Results: Salvage index was significantly greater in the stent group (median 0.60, [25th, 
75th pementiles: 0.37, 0.82]) than in the alteplase group (median 0.41, [0.13, 0.58]), 
P=0.001. By 6 months, 4.9% of the stent group and 8.6% of the fibrinolysis group had 
died, relative risk of 0.56 [95% confidence interval, 0.17-1.88], P=0.35. The combined 
incidence of death and recurrent myocardial infarction was 7.4% in the stent and 17.3% 
